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Abstract
Objectives: This literature review reports the current evidence for the use of zygomatic implants in head and 
neck oncology patients for the prosthetic rehabilitation of defects of the mid-face and maxilla. Methods: 
MEDLINE, Embase and Cochrane databases were searched using strict search terms. Two independent 
reviewers reviewed the articles and applied inclusion and exclusion criteria. Results: Literature search 
revealed 437 articles, and following application of the inclusion criteria, 32 articles were included for analysis. 
Overall survival rates of 77-100% were reported with few complications, although only 4 centres presented 
data on 20 or more patients. Primary implant placement at time of resective surgery has been shown to be an 
effective means of accelerating rehabilitation along with early loading protocols. The role of radiotherapy in 
implant failure has not been fully elucidated and it is clear that zygomatic implants can be successfully used in 
the irradiated patient. Providing support for maxillary obturators was the most common use reported with 
both splinted and unsplinted implants. 
Conclusions: Zygomatic Implants provide remote anchorage for a variety of oral and facial prostheses that 
contribute to the improved function and quality of life for patients being treated for maxillary and mid-facial 
tumours.
Introduction
Malignant diseases of the head and neck require radical treatment, often resulting in loss of the dentition and 
supporting structures, facial defects and drastic changes in anatomical form. The implications of this are life-
changing, often associated with the loss or hinderance of function, speech, swallowing, and appearance, 
leading to a detrimental effect on the patient’s social and psychological wellbeing. Maxillary and mid-facial 
defects are complex and can be classified by level using classifications such as that by Brown (Brown & Shaw, 
2010) and Okay (Okay, Genden, Buchbinder, & Urken, 2001) to assist in treatment planning, resection, 
surgical reconstruction and prosthodontic rehabilitation.
In 1998, Professor PI Branemark’s team developed the specifically designed zygomatic implant for use in 
compromised maxillary bone including severe atrophy, congenital defects and tumour resection defects 
(Brånemark, 1998). In 2001, his team published the first paper (Parel, Brånemark, Ohrnell, & Svensson, 2001) 
on the survival of these implants placed in to the residual zygomatic buttress in patients with maxillary 
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for the development of zygomatic implants in the management of patients with maxillary tumour defects 
with the high quality bone of the zygoma providing excellent anchorage for long implants cantilevered into 
the defect to provide prosthetic support and retention.
With advancing techniques in this field, zygomatic implant design has evolved from the traditional implant 
design with roughened threads throughout the entire length to ‘oncology-zygomatic implants’ with threads 
only at the implant apex which engage in the residual zygomatic buttress bone. These modified implants were 
thus more cleansable when exposed into maxillary and midfacial defect situations. In addition, surgeons have 
continued to evolve the techniques to use these implants intra-orally and extra-orally to improve the quality 
of prosthodontic and prosthetic facial rehabilitation.
Whilst the implementation of zygomatic implant treatments in head and neck cancer patients is an evolving 
and increasingly popular technique, there is still a paucity of evidence available in the literature  reporting 
useful data regarding techniques, implant survival, prosthetic variables as well as the influence of important 
decision making variables such as timing of placement, loading and the effects of radiotherapy on treatment 
success. The purpose of this literature review is to attempt to assimilate the available data and provide 
recommendations for clinical application.
Aims
The aim of this literature review is to review the published evidence for the use of zygomatic implants in head 
and neck oncology patients to rehabilitate maxillary and midface defects. Table 1 lists the PICOS criteria used 
in establishing the research question.  The specific areas of focus during the review were:
 To examine trends in current protocols for the placement of zygomatic implants to retain midface 
and oral maxillary prostheses.
 To examine the survival of zygomatic implants in head and neck oncology patients published in case 
series and cohort studies. This included looking for differences in survival of those implants placed at 
primary oncology surgery compared to those placed at a later timepoint, in patients who had and had 
not received radiotherapy and in patients with differing prosthetic loading times. 
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 To analyse published case reports and articles where zygomatic implants have been provided to 
ascertain innovative or developing techniques, trends in types prostheses provided and speed of 
prosthesis delivery from the time of implant placement.
Materials and methods
MEDLINE and Embase databases were searched using the following search terms: head and neck OR oral OR 
maxillofacial OR craniofacial OR jaw OR maxill* OR nasal OR naso*maxilla* OR zygoma* OR midfac* OR 
cancer OR tumour OR tumor OR malignan* OR obturat* OR rehabilitat* OR reconstruct* OR prosthe*))) AND 
(zygoma* AND (implant OR implant-support*))) NOT atroph*. No date limit was set on the search to 
maximise the amount of data collected.
We also searched the entire Cochrane Library database for all dates to 6th October 2019 using the keywords: 
implants AND oral cancer.
Two independent reviewers (SH and BE) reviewed the titles and abstracts from all articles produced by the 
searches. Full text articles were reviewed of articles which were unclear from the titles or abstracts and were 
only included if both reviewers agreed that the article met the inclusion criteria. Hand searching of reference 
lists of included articles was also performed to check for additional articles which were not found in the 
original searches. 
Included papers were those which reported on zygomatic implant placement in head and neck oncology 
patients. Implants could be of either zygomatic or zygomatic-oncology types. Included articles could be from 
randomised and non-randomised control trials, cohort studies, case-control studies, case reports and reviews 
only. All papers included were written in English. 
Exclusion criteria included articles referring to or investigating diseases or patient status other than head and 
neck cancer, that did not include the placement of zygomatic implants or where authors had placed dental 
implants in the zygoma, referring to diagnostic or imaging studies, where there was insufficient data on 
zygomatic implant survival or number of head and neck cancer patients in the study and those that were not 
written in English language. Duplicate articles were removed. Articles which included head and neck cancer 
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For this review, ‘implant failure’ includes complete loss of the implant only. ‘Complications’ refer to issues 
arising around or involving an implant in situ. Articles which reported the outcomes of greater than or equal 
to 4 head and neck cancer patients with zygomatic implants were considered as case series and those which 
reported the outcomes of 1-3 patients were considered as case reports.
Results
The search term produced 432 articles from MEDLINE and Embase and 5 articles from the Cochrane Library 
database. Following application of the inclusion/exclusion criteria, 12 case series and 20 case reports were 
included for review, which included 10 case series and 15 case reports relating to maxillary rehabilitation, and 
2 case series and 5 case reports relating to midface (extraoral) rehabilitation (Figure 1). 
Table 2 and Table 3 give an overview of the case series and case reports included in this review. Most studies 
reported retrospective data, with the exception of the studies by Butterworth (Butterworth, 2019) and 
Pellegrino et al (Pellegrino, Tarsitano, Basile, Pizzigallo, & Marchetti, 2015) which were prospective in nature. 
Studies ranged remarkably in sample size from 4 to 49 patients, with a total of between 9 to 131 zygomatic 
implants placed in head and neck cancer patients. Only 4 studies presented data including 20 or more 
patients. Follow up periods ranged from 0 to 163 months. 
Midface rehabilitation using zygomatic implants
Standard length implant placement in the midfacial region has long been used to retain nasal prostheses with 
implants placed mainly in the nasal floor. Zygomatic implant placement in the horizontal plane is a more 
recent concept, first reported by Bowden in 2006 (Bowden, Flood, & Downie, 2006) as a rescue procedure 
following failure of nasal floor implants providing remote anchorage in to the zygomatic buttress (Figure 2). 
Only one large (n=28 patients) (Scott, Kittur, Evans, Dovgalski, & Hodder, 2016) and one small (n=5) study 
(Ethunandan, Downie, & Flood, 2010) have reported on the survival of zygomatic implants for midfacial 
prostheses. In addition, a prospective series (Butterworth, 2019) reported on their use with both primarily 
and secondarily placed implants. In the larger of the studies by Scott et al. (2016), 56 zygomatic implants were 
placed in 28 patients requiring nasal reconstruction, and were followed up for 1-10+ years. Only one implant 
failed (survival 98%) in a male patient who underwent a total extended type of nasal resection and post-
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zygomatic implants to be placed were to be offset at 3-4mm higher than the other. This allowed better access 
during implant placement and facilitated better cleaning for the patient. A 3D surgical guide was produced to 
ensure zygomatic bone was engaged at the correct site whilst keeping the desired offset position of the 
implants. The two zygomatic implants were placed primarily at the time of tumour resection surgery. The 
authors advised preservation of the nasal bones where possible to provide a firm base for the prosthesis as 
well as advancement of the skin over the surgical margins to reduce tissue mobility under the final prosthesis. 
They allowed 6 weeks for osseointegration before loading these implants where radiotherapy was not used 
or waited until radiotherapy was completed before loading was undertaken. Patients wore a temporary nasal 
prosthesis whilst waiting for implant loading. The final silicone facial prostheses were retained using 
individual magnetic abutments applied to both implants. Common issues with the initial nasal prostheses 
were reported including shrinkage of the surrounding soft tissues during healing leading to a prominence of 
the fine edges of the nasal prostheses. Patients were also found to suffer rhinorrhoea at inferior margins of 
the prostheses. The authors recommended a maintenance protocol of replacement prosthesis every 2 years, 
allowing for modification of skin shade matching. Nasal secretions were managed with both medication and a 
flange on nasal cavity side of the prosthesis, directing secretions away from inferior margin and avoiding 
leakage. 
Where patients have combined maxillary and facial defects, novel techniques have been reported using 
frameworks supported by zygomatic implants to retain both an oral as well as a facial prosthesis (Gonçalves 
et al., 2015; King, Abbott, Dovgalski, & Owens, 2017; Trevisiol et al., 2016). These frameworks have 
attachments at the cranial (superior) and oral (inferior) surfaces to support obturators and nasal prostheses 
concurrently with implants being placed either horizontally or conventionally via an intra-oral approach 
(Figure 3). 
Maxillary Rehabilitation using Zygomatic Implants
Implant survival
Data sourced from the included case series demonstrated overall good survival rates of zygomatic implants 
for maxillary reconstruction (Table 2). Of the included case series, the overall survival rates of oral zygomatic 
implants was 77-100%, with variability in survival rates found between the reporting institutions. Butterworth 
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the 131 implants placed, 9 implants were removed from 4 patients; 6 within 4 months of placement, 2 within 
12 months and 1 after 3 years. Kaplan-Meier survival curves showed an estimated 94% 1-year survival and 
92% 5-year survival of zygomatic implants placed in head and neck oncology patients. Boyes-Varley et al 
(Boyes-Varley, Howes, Davidge-Pitts, Brånemark, & McAlpine, 2007) placed 40 zygomatic and 66 conventional 
implants in 20 patients during primary resection surgery with a 100% survival rate for the zygomatic implants 
in a follow up period of 1-108 months. The lowest survival rate reported was 77% in a study to evaluate the 
clinical outcome of maxillary reconstruction with zygomatic implants after extensive maxillectomy (Schmidt, 
Pogrel, Young, & Sharma, 2004). 5 out of 22 zygomatic implants failed in 7 oncology patients during a 2-3 year 
follow up period. All failures occurred at stage 2 implant surgery prior to prosthetic rehabilitation.
Surgical complications following zygomatic implant placement included those related to osseointegration 
failure, poor placement or positioning, formation of communication between maxillary sinus and oral cavity, 
nasal leakage and mucosal complications. On the whole, there were relatively few complications reported in 
the literature in relation to these techniques. Boyes-Varley et al (Boyes-Varley et al., 2007) reported 
complications by number of visits which patients had attended post-operatively, but none of the following led 
to implant failure; Trismus was the most common surgical complication (6.8%), followed by pain (4.5%), 
paraesthesia (2.3%) and contracture (2.3%). 
Zygomatic implant survival rate in patients who have received radiotherapy vs. no radiotherapy
The use of adjuvant radiotherapy/chemoradiotherapy is common for patients with maxillary and mid-facial 
malignant disease especially where there is advanced disease with locoregional spread, or where there are 
close surgical margins. Whilst radiotherapy fields are targeted to the diseased sites, the bony skeleton 
including the zygomatic bodies is often subject to irradiation and healing potential is potentially diminished. 
Any surgical intervention involving irradiated bone, including dental or zygomatic implant placement can lead 
to compromised healing or osteoradionecrosis. However, the risk of this must be considered against gaining 
functional oral or nasal rehabilitation with the use of implants, since patients often have difficulty wearing 
conventional prostheses due to mucosal irritation, dryness or ulceration. 
Landes et al (Landes et al., 2009) placed zygomatic implants on average after 18 months disease-free interval. 
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chronic infection, who went on to have 4 more zygomatic implants placed around the infection site and 
contralaterally into iliac free flap. Schmidt et al. (2004) reported a 31% failure of zygomatic implants placed in 
irradiated patients where 2 implants failed in a patient who received pre-implant radiotherapy, and 3 
implants failed in a post-implant radiotherapy patient. How many of the failures in these small series were 
caused primarily by the effects of radiotherapy is impossible to say as failure is multi-factorial and may have 
been related to operator inexperience at the beginning of a significant learning curve. Butterworth 
(Butterworth, 2019) did not specifically analyse the failure rates due to radiotherapy although 8 patients in his 
secondary group were irradiated before implant placement and 15 patients in the primary group were 
irradiated immediately post-operatively. The high survival rates reported in larger series demonstrates that 
successful integration can occur in irradiated patients.
Is there a difference in survival between primary and secondary placement?
In recent years there has been a developing paradigm shift towards placement of zygomatic implants at 
primary maxillary tumour resection surgery as a means of accelerating prosthetic rehabilitation and 
potentially avoiding the issues of surgery in the irradiated field (Boyes-Varley et al., 2007; Butterworth). Close 
working relationship between surgical and prosthodontic teams is mandatory to execute this treatment 
modality effectively (Vosselman et al., 2020 (in press)).  Butterworth (Butterworth, 2019) assessed the 
differences in survival of zygomatic implants between primary and secondary placement protocols in a larger 
study and found 4% failure in the primary group compared to 11% failure in the secondary group. Both 
groups were comparable in terms of age, gender, and smoking status. The hazard ratios suggested a doubling 
(HR = 2.25) of risk of failure with secondary placement relative to primary placement. This evidence supports 
that of Boyes-Varley et al (Boyes-Varley et al., 2007) who placed a total of 40 zygomatic implants at primary 
ablative surgery with a survival of 100% at 4-108 months (mean 31 months). 
Is there a difference in survival between immediate vs. delayed loading? 
The conversation of immediate versus delayed loading of conventional dental implants has long been 
discussed and continues to be advocated for zygomatic implants. Oncology patients with maxillary and 
midfacial defects have great demands to be restored to function as soon as possible post-operatively and 
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resections. The literature search revealed a variety of loading protocols and techniques including immediate, 
early and delayed loading (Table 4).
Time to loading periods in the included case series ranged from 72 hours to 6 months. Pellegrino et al 
(Pellegrino et al., 2015) loaded the zygomatic implants in 4 out of 5 patients within 72 hours and provided a 
definitive prosthesis within 3 months.  One implant failed after 8 months of loading.  Butterworth 
(Butterworth, 2019) loaded 27 out of 49 patients (primary placement group) within a mean time of 1.7 
months and the remaining 22 patients in the secondary placement group had a delayed loading time (mean 
9.3 months). Implants in the secondary (delayed loading) group had higher rates of failure (11% compared to 
4%) but the secondary group was also disadvantaged by pre-treatment radiotherapy.
Other authors immediately loaded the zygomatic implants utilising other structures for support in the 
immediate healing period to avoid overloading recently placed implants. Boyes-Varley et al (Boyes-Varley et 
al., 2007) provided an immediate surgical obturator which was supported by zygomatic implants and 
transosseous screws in the remaining palate. A definitive cast titanium superstructure was then placed at 3 
weeks post-resection and a definitive fixed-removable obturator placed within 9 weeks post-resection. This 
study followed up patients during a period of loading up to 96 months with 100% survival rate. Although not 
necessarily immediately loading the implants, Zwahlen et al (2006) (Zwahlen, Gratz, Oechslin, & Studer, 2006) 
suspended a surgical obturator from the zygomatic arch using wires during the osseointegration period, 
which lasted an average of 8 months. During this period, they also splinted the zygomatic implants with a 
rigid bar to avoid potentially damaging off-axis loading of the zygomatic and additional conventional implants.
The majority of studies loaded the implants after a delayed period of healing of typically 2-6 months and 
some provided temporary obturators during this time (Atalay, Doğanay, Saraçoğlu, Bultan, & Hafiz, 2017; 
Huang et al., 2014; Landes et al., 2009). 
Unilateral zygomatic implants and cross-arch splinting
The conclusions from Professor Branemark’s initial study (Parel et al., 2001) , recommended that effective 
axial loading of the implants should be accomplished by cross-arch stabilisation, using at least 4 implants, 
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the edentulous patient, it is not possible in patients with partial maxillary defects where high quality teeth on 
the non-defect side are reasonably retained. In these situations, unilateral zygomatic implant placement has 
been shown to be of benefit with either a single or two implants being placed on the defect side (Figure 4) 
(Qu, Wang, Ong, & Zhang, 2016). 
Unilateral zygomatic implants have also been reported in a paediatric patient, who underwent hemi-
maxillectomy for myxoid spindle cell carcinoma (Dattani, Richardson, & Butterworth, 2017). Two zygomatic 
implants were placed on the resected side at the time of primary surgery and restored with a bar retained 
obturator. The implants were splinted, enabling adequate axial loading and anterior-posterior spread and 
were loaded after a 3 month osseointegration period. 
Uses of zygomatic implants and definitive prostheses design
Clinicians have a number of prosthodontic options available to complete maxillary rehabilitation using 
zygomatic implants. The final prosthesis will ultimately be determined by clinical and laboratory experience, 
space availability in horizontal, vertical and antero-posterior planes, implant positioning, aesthetic 
requirements, access due to trismus and ease of retrievability. Many clinicians decided to splint the implants 
together with a bar or similar structure to distribute occlusal forces amongst all implants. Table 4 summarises 
the prosthesis types and loading protocols presented in the included case series. 
Wang et al (Wang et al., 2017) compared two groups of patients: one group rehabilitated with removable 
prostheses supported by dental and zygomatic implants; the other group with fixed prostheses on dental 
implants. Of the removable group, 8 were provided magnet obturators, 4 bar overdentures, 2 locator 
overdentures, 2 ball overdentures and 2 were combination attachment removable prostheses. This study 
concluded ‘no difference in oral function between patients with implant supported obturators and implant 
supported fixed prostheses in free vascularised flaps after a maxillectomy.’ However, within the limitations of 
the study, it was found that patients who received removable obturator prostheses had poorer mental health 
than patients with fixed prostheses.
Where patients were rehabilitated with fixed-removable prostheses, authors tended to favour a milled bar to 
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Darwood, & Tanner, 2015; Gonçalves et al., 2015; Hirsch, Howell, & Levine, 2009). Bars can be further 
modified with attachments such as Rhein attachments to aid prosthetic retention (Dattani et al., 2017).
Despite many authors favouring removable prostheses, some case studies reported the use of fixed 
bridgework on zygomatic implants (Boyes-Varley et al., 2007; Butterworth, 2019; Huang et al., 2014; 
Pellegrino et al., 2015; Wang et al., 2017), with very few complications. The main complications included 
screw loosening and the more problematic screw fracture. 
Data on bite force and prosthesis retention can be achieved by the use of zygomatic implants insertion in 
hemi-maxillectomy patients (Qu et al., 2016). A control group received tooth-supported obturator prostheses 
with no implant support and the experimental group received prostheses with additional zygomatic implant 
support on the defect side. Eight of the ten test patients received 1 zygomatic implant which was restored 
with a magnetic abutment with the other two patients receiving 2 zygomatic implants and magnetic 
abutments. Results showed that although the use of a zygomatic implant did not significantly improve 
prosthesis retention (however patients reported subjective improvement in this), the bite force recorded at 
the prosthetic first molar was significantly increased after implant insertion. 
Quality of life
Quality of life (QoL) data was presented in numerous formats. In general, authors found that head and neck 
cancer patients who received zygomatic implant prostheses had postoperative favourable speech (Huang et 
al., 2014; Lu, Wang, Yang, & Yan, 2013; Schmidt et al., 2004), acceptable aesthetics or facial contour (Huang 
et al., 2014; Schmidt et al., 2004) and adequate eating and drinking function without nasal leakage (Schmidt 
et al., 2004). 
A common dental quality of life indicator is the Oral Health Impact Profile (OHIP-14). A low score (=0) 
indicates no impairment, to the highest score (=56) indicating maximal impairment. Pellegrino et al 
(Pellegrino et al., 2015) reported an OHIP-14 score mean of 10 points improvement between the pre-
operative and 6 month post-operative assessments. Landes (Landes et al., 2009) reported a 9 year follow up 
study and found a worsening in OHIP-14 scores from 14±6 pre-treatment to 25±12 post-rehabilitation.  They 
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aesthetic acceptance when interviewed. This highlights the need to use quality of life indicators with caution 
in head and neck cancer patients, whose QoL is likely to be worsened to a large degree following cancer 
treatment although rehabilitation modalities can lessen that degree of debilitation.
Butterworth (Butterworth, 2019) utilised version 4 of the University of Washington-QoL scale (UW-QOL) to 
assess changes in QoL with zygomatic implant treatment. This questionnaire provides questions that are 
specific to patients with head and neck cancers and is concise yet multifactorial, allowing for sufficient detail 
from responses (Lowe & Rogers, 2012). Following zygomatic implant restoration, most patients (60%) were 
able to swallow as well as ever and none had significant problems in regard to swallowing. However, 72% 
recognised a change in appearance, although only one patient had a significant problem with this. With 
regards to the overall QoL, 72% (18) said it was “good,” “very good,” or “outstanding”.
Case report analysis
Due to the limited number of case series and the relatively early use of zygomatic implants in maxillectomy 
patients, case studies offer valuable information on innovative and developing techniques which could be 
considered for use in clinical practice. The case reports collected in the search offer information on survival, 
digital pathways, fixture and prostheses types and surgical techniques (Table 3).
Digital dentistry and surgery are being rapidly adopted into the standardised workflow for dental implant 
surgery and most implants placed today are planned and rehearsed meticulously with the use of 3D imaging, 
optical scanners and planning software. Surgical guides can be printed prior to surgery to enable operators to 
place implants in a prosthodontically driven fashion. Chen et al. (Chen, Wu, & Wang, 2011) reported a single 
case using a self-developed navigation system (AccuNavi) to overcome the issues of surgical instability of CT-
drill guides in maxillary defects due to insufficient bone. Their computer-aided navigation system reportedly 
allowed real-time, interactive, intraoperative data to transfer the precise pre-operative planning to the 
patient in zygomatic implant placement, with less than 1mm positioning accuracy. However, their technique 
required significant time for set-up and treatment including the insertion of multiple fiducial markers into 
both the remaining hard palate as well as the fixation of a tracking device directly into the frontal region of 
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specifically designed to be placed from an extra-oral position through the facial skin in order to simplify 
placement in a patient with limited mouth opening and oral access.
Speed of prostheses delivery from the time of implant placement can be increased by an  immediate fixed 
construction on customised zygomatic implants (Ekstrand & Hirsch, 2008). The surgery was planned pre-
operatively on stereolithographic models of pre- and post-resection. A bridge was fabricated from 
poly(methylmethacrylate) reinforced with carbon/graphite fibres. The patient was also provided a soft 
silicone-lined obturator constructed from the same master cast to obturate the palatal defect. Early 
reconstruction was found to improve clinical outcomes, preventing contraction and the formation of scar 
tissue, ensuring adequate mouth opening and function. In QoL outcome measures, patients reported 
improved healing and functional experiences when provided with fast rehabilitation, with reduced pain and 
discomfort (Ekstrand & Hirsch, 2008).
Butterworth and Rogers (Butterworth & Rogers, 2017) also developed a protocol whereby rapid oral and 
dental rehabilitation could be provided within a few weeks of resective surgery with the advantage of 
immediate palatal defect closure. The zygomatic implant perforated micro-vascular soft tissue flap (ZIP flap) 
technique was developed, whereby zygomatic implants placed at primary surgery perforate the soft tissue 
reconstruction flap and are readily available to support a maxillary fixed dental prosthesis. Polythene washers 
were placed at the intraoral interface of the zygomatic implant/free flap to prevent flap overgrowth during 
initial healing period (Figure 5).  This technique allows rapid return to function and restoration of appearance 
following low-level maxillary resection, even in cases where radiotherapy is required as an adjuvant 
treatment post-operatively. The reported patient exhibited very good QoL measures. This technique is a 
single-stage improvement on the 2-stage procedure described by Hirsch et al (Hirsch et al., 2009) where a 
palatomaxillary defect was initially reconstructed with radial forearm free flap with subsequent zygomatic 
implant placement used to support the provision of a bar-retained overdenture. Additionally, the ZIP flap 
technique provides a much more rapid alternative to the fixed dental rehabilitation techniques involving 
grafted bone such as the fibula flap even when digital technologies are employed in order to reduce 
treatment times (Seikaly et al., 2019). Further ongoing studies will be required to examine both these 










This article is protected by copyright. All rights reserved
Conclusions
This paper has attempted to review the current evidence for the use of zygomatic implants in midface and 
maxillary rehabilitation of head and neck cancer patients. Although currently limited, the evidence suggests 
overall good survival rates for the use of zygomatic implants, however there are varied institutional results 
reported, most likely due to differing levels of experience with these techniques which have a distinct 
learning curve. The results from the larger series are extremely encouraging and confirm the predictability of 
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Figure 2 
Posterior-anterior skull radiograph demonstrating the horizontal positioning of two zygomatic implants to 
provide support for a nasal prosthesis in a patient following rhinectomy.
Figure 3
A combined maxillary & mid-facial defect utilising horizontal zygomatic implant supported bar magnet to 
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Figure 4
Unilaterally splinted zygomatic implants used to support a maxillary obturator
Figure 5
Maxillary ZIP flap technique (30) providing a microvascular flap closure of the left maxilla with zygomatic 











Population Head and neck oncology patients
Intervention Zygomatic implant placement
Control No control
Outcomes Survival, implant/prosthetic complications, quality of life
Study designs RCTs, cohort, cross-sectional, case-control, case series, case reports
Table 1: PICOS criteria used for literature review 
Author Study type
Number of oncology patients receiving 
zygomatic implants
Number of zygomatic implants 
placed in oncology patients
Follow up period (months) Fixture type
Overall survival rates of 
zygomatic implants
% incidence zygomatic implant 
failure in radiotherapy treated 
patients
% failures of implants placed at 
primary surgery




Butterworth (2019) Prospective case series 49 131 2 - 110
Zygomatic (73/131) and zygomatic-
oncology (58/131)
93% Not stated 4% (n= 3/75) 11% (n=6/56)
No complications in primary placement group. Secondary group: early skin infections (n=2), delayed 
chronic infections (n=2)
Atalay et al (2017) Retrospective case series 6 32 6 - 36 Zygomatic 100% 0% Timing of placement not indicated Timing of placement not indicated Peri implant mucositis (9.3%)
Pellegrino et al (2015) Prospective case series 4 13 10-29 
Zygomatic; zygomatic-oncology via 
skin flaps
93% Not stated
Not stated (n=1 placed at primary 
surgery)
Not stated (n=3 placed at 
secondary surgery)
No incidents of peri-implantitis or local inflammation occurred during follow up period
Huang et al (2014) Retrospective case series 5 9 0-125 Zygomatic 89% RT patients excluded Timing of placement not indicated Timing of placement not indicated 1/9 implants peri implant infection, 1/5 patients flap dehiscence
Wang et al (2013) Retrospective case series 15 24 Unknown Zygomatic 100% 0%
Not stated (n = 5 placed at primary 
surgery)
Not stated One zygomatic implant poor placement, not used in prosthesis
Boyes-Varley et al (2007) Retrospective case series 20 40 4-108 
Zygomatic and zygomatic-
oncology
100% 0% 0% (n = 40) - Trismus (6.8%), pain (4.5%), paraesthesia (2.3%), contracture (2.3%). Recorded by number of visits
Zwahlen et al (2006) Retrospective case series 5 9 6 Zygomatic 100% Not stated Timing of placement not indicated Timing of placement not indicated
5.9% post-operative complications – led to loss of both zygomatic implants in one patient- bilateral 
sinusitis
Landes (2005) Retrospective case series 10 28 13-102 Zygomatic 89% 18% 100% (n=1) 7% (n=2) Chronic zygomatic implants infection = 11% (includes oncology, CLP & AI patients)
Schmidt et al (2004) Retrospective case series 7 22 24-36 with prosthesis Zygomatic 77% 31% 50% (n=2) 12.5% (n=5) No surgical complications encountered
Parel et al (2001) Retrospective case series 24 up to 59 Up to 144 Zygomatic 100% Unknown Timing of placement not indicated Timing of placement not indicated None reported
Midface Case Series
Scott et al (2016) Retrospective case series 28 56 12-120+ Zygomatic 98% 8% 2% All placed at primary surgery No surgical complications encountered
Ethunandan et al (2010) Retrospective case series 5 8 4-108 Zygomatic 87% Not specified 13% All placed at primary surgery
Two-stage proedure of uncovering inplants was associated with higher frequency of failure vs. one-
stage. All failures occurred in patients who had received pre-operative radiotherapy 
Table 2: Summary of included case series (maxilla and midfacial rehabilitation), reported 
survival rates and surgical complications
Author
Number of oncology 
patients receiving 
zygomatic implants
Number of zygomatic 
implants placed 
Follow up period Placement timing Loading timing Prosthesis Failures Comments
Maxilla Case Reports
Binon (2017) 1 2 5 years Secondary > 6 months
Titanium bar with fixed 
bridge, additional 
attachment for mid-palatal 
obturator component 
Hybrid prosthesis design- fixed bridge with removable 
component to occlude palatal defect
Butterworth and Rogers 
(2017)
1 4 18 months Primary 4 weeks Fixed bridge
Zygomatic implant perforated flap (ZIP). Primary implant 
placement and soft tissue reconstruction flap for low 
level maxillary defects
Dattani et al (2017) 1 2 2 years Primary 4 months
Bar overdenture, Rhein 
attachments
Unilateral zygomatic implant placement to support 
obturator in a paediaric patient. No deleterious effect on 
craniofacial growth
Salvatori et al (2017) 3 5 Not specified Primary > 3 months Fixed bridges
1 patient experienced 
suture dehiscence managed 
conservatively 
Low level alveolectomy cases x 2 closed with buccal fat 
pad plus 1 partial maxillectomy closed with temporalis 
flap. Zygomatic implants placed at primary surgery and 
exposed 3 months later.
Ozaki et al (2016) 1 2
18 month post implant 
placement
Secondary 6 months Magnet obturator
Sub-total low level maxillectomy with individual magnet 
abutments to support a removable obturator
Fernandes et al (2016) 1 4 6 months Secondary 3 Days
Modified implant-supported 
interim obturator and nasal 
prosthesis
4 implants failed at 4 weeks 
- failure to osseointegrate
Maxillectomy, rhinectomy, upper lip and cheek 
resection. Large titanium midfacial prosthesis 
constructed as an alternative when initial zygomatic 
implants failed.
Dawood et al (2015) 1 1 2 years Secondary Not specified Milled bar and overdenture
Report of a custom designed Zygomatic implant which 
could be placed via an extra oral approach. 
Celakil et al  (2015) 1 2 1 year Secondary Not Specified
Milled bar and overdenture/ 
obturator
Sub-total maxillectomy with 2 Zygomatic implants, a 
CAD/CAM milled bar to support an obturator prosthesis
D'Agostino et al (2013) 1 3 1 year Secondary 9 months
Custom abutments, 
overdenture
Sub-total bilateral maxillectomy supported with 3 
zygomatic implants and individual custom made 
retentive abutments
Pia et al (2012) 1 2 12 months Secondary 2 weeks Bar retained overdenture
Previous obturator patient treated with initial temporalis 
flap defect closure and Zygomatic implant placement 6 
months later.
Shirota et al (2011) 1 4 2 years Secondary 6 months Milled bar and overdenture
Sub-total maxillectomy with 4 zygomatic implants and 2 
dental implants into tuberosities. Bilteral splinted bars to 
retaine obturator
O'Connell et al (2011) 1 3 18 months Secondary Not specified Bar overdenture
1 failed before prosthesis, 
prosthesis therefore loaded 
on remaining 2 implants
Sub-total maxillectomy with 2 zygomatic implants 
supporting a bar-retained obturator
Hirsch et al  (2009) 2 4 Not specified Secondary 6 months
1 bar overdenture, 1 partial 
overdenture
Novel approach to palatomaxillary reconstruction using a 
combination of radial forearm free flap transfer and 
secondary zygomatic implant placement 
Ekstrand and Hirch (2008) 1 2 Not specified Secondary 6 months
Fixed bridge and separate 
silcone obturator prosthesis 
used
Introduced virtually-planned custom-made 'R-zygoma' 
fixtures 20mm length in a partial maxillectomy case. One 
placed horizontally into the anterior hard palate superior 
to the apices of the teeth and one into the zygomatic 
stump
Hu et al (2007) 1 1 12 months Primary 6 months Fixed bridge
Left hem-maxillectomy reconstructed with Vascularised 
iliac crest flap which was anchored with a single 
zygomatic implant
Midface Case Reports
King et al (2017) 3 6 Not specified Primary
Loaded after soft tissue 
healing
Nasal and obturator via 
magnet
1 fractured nasal bar
Rhinectomy and partial maxillectomy patients with 
insertion of horizontal zygomatic implants restored with 
Custom-milled bar-magnet used to retain both the 
maxillary obturator and nasal prostheses 
Trevisiol et al  (2016) 1 4 Not specified Secondary 4 weeks
Custom made oronasal bar, 
ball abutments in nasal 
aspect of prosthesis
Zygomatic implant supported full-arch maxillary bar 
extends through oronasal communication to provide 
nasal epithesis anchorage. Zygomatic implants placed 
conventioanlly intra-orally
Goncalves et al  (2015) 1 4 6 years Secondary > 6 months
Milled bar, denture, nasal 
prosthesis
1 out of 4 implants failed
Large mid-facial resection managed with separate oral 
and nasal prostheses. Single titanium framework with 
Locator attachments to retain both prostheses.
Walivaara et al (2010) 1 2 Not specified Secondary 5 months
Magnet retained nasal 
prosthesis
Accurate horizontal zygomatic implant placement aided 
by computer designed and fabricated facial surgical 
guide with minimal access flaps
Bowden et al (2006) 2 4 2 years Secondary Delayed - 4 months
Magnet retained nasal 
prosthesis
Zygomatic implants placed horizontally from piriform 
fossa to zygoma to retain nasal prosthesis aftr failure of 
nasal floor implants
Table 3: Summary of 
included care reports
Author Type of loading Average time to loading Prosthesis type Prosthodontic complications
Maxilla Case Series
Butterworth (2019) 
Primary placement group early loading; 
secondary placement group delayed loading
Early 1.7 months; delayed 9.3 months
11 fixed bridges, 20 obturators, 5 overdentures, 
15 facial prostheses
Small number of patients experienced screw loosening, screw fracture. 1 significant prosthodontic 
maintenance (where two zygomatic implants supported obturator opposed against natural dentition
Agbara et al (2017) Delayed Not stated Obturators Not stated
Atalay et al (2017) Delayed 2 months Obturators 1 fractured abutment screw at 5 months
Pellegrino et al (2015)  Mostly immediate loading Within 72 hours; definitive prosthesis 3 months Fixed bridges No complications reported
Huang et al (2014) Delayed 3 months 4 fixed bridges, 1 obturators Screw loosening- number of zygomatic implants affected unknown
Wang et al (2013) Not stated Not stated Obturators 1 implant poor placement and not used in prosthetic loading
Boyes-Varley et al (2007) 
Immediate surgical obturator; definitive cast 
titanium superstructure at 3 weeks
3 weeks 2 fixed bridges, 18 obturators
Speech (38.6%), nose leakage (11.4%), food leakage (9.1%), screw loosening (9.1%), prosthesis mobility (6.8%), 
prosthesis fracture (6.8%), screw fracture (2.3%) – by number of visits
Zwahlen et al (2006) Delayed 8 months Obturators Not stated
Landes (2005) Delayed 6 months Obturators/overdentures
1 zygomatic implant failed due to being overloaded. Tendency for shorter implants to be prone to recurrent 
infection with pocketing and local infection
Schmidt et al (2004) Not stated Not stated Obturators Not stated
Parel et al (2001)
Delayed
5-6 months Not stated Not stated
Midface Case Series
Scott et al (2016)
Delayed
6 weeks post-operatively or after radiotherapy 
(interim temporary prosthesis worn)
Facial prostheses
Soft tissue shrinkage around prosthesis resulting in prominence, rhinorrhoea at the prosthesis inferior margin
Ethunandan et al (2010)
Delayed 5.7 months (range 1 week to 18 months) Facial prostheses
Increased rate of failure with bars (33%) vs magnet-retained (9%) prostheses
Table 4: Maxilla and mid-facial rehabilitation case series - loading protocols, prosthesis types and prosthodontic complications
